Latest News

Kimberly-Clark Announces Preliminary Third Quarter 2026 Results and Provides Full Year 2026 Outlook Consistent with Previous Expectations

INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

First Advantage to Release Third Quarter 2026 Financial Results and Hold Investor Conference Call on November 5, 2026

Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome

SunCoke Energy, Inc. Announces Third Quarter 2026 Earnings Date

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Redwire Secures Additional Orders to Deliver Stalker UAS to U.S. National Guard for the Army’s Next-Generation Drone Operators

Core Scientific, Inc. Schedules Third Quarter Fiscal Year 2026 Earnings Release, Conference Call and Webcast